LeadIQ logo
Learn more at LeadIQ.com

Insights

Strategic Collaborations Brii Bio's recent partnership with Joincare Pharmaceutical Group Industry Co., Ltd presents a significant opportunity to offer complementary solutions, licensing, or distribution services within the Asia-Pacific region, leveraging their expanding alliance network.

Innovative Pipeline The company’s focus on innovative hepatitis B therapies such as BRII-179 and PreHevbri expands potential sales avenues in the infectious disease market, especially through their licensing and development of vaccines and therapeutic candidates.

Geographical Expansion With operations in key biotech hubs including Raleigh-Durham, Beijing, and Shanghai, Brii Bio is positioned to benefit from and contribute to regional biotech ecosystems, offering regional partners tailored clinical, manufacturing, or distribution collaborations.

Financial Growth Brii Bio’s revenue of up to $500M, supported by a recent funding boost of $155M, indicates a solid financial foundation conducive to expanding their portfolio, accelerating clinical development, or entering new market segments.

Leadership & Talent The appointment of a new Chief Scientific Officer and deep scientific expertise highlight their commitment to innovative R&D, creating opportunities for research partners, technology providers, or custom collaboration to enhance their therapeutic pipeline.

Brii Biosciences Tech Stack

Brii Biosciences uses 8 technology products and services including NetSuite, Apple iCloud Mail, Microsoft, and more. Explore Brii Biosciences's tech stack below.

  • NetSuite
    E-commerce
  • Apple iCloud Mail
    Email
  • Microsoft
    Miscellaneous
  • Microsoft Word
    Office Suites
  • Microsoft Azure
    Platform As A Service
  • PHP
    Programming Languages
  • Google
    Search Engines
  • X-XSS-Protection
    Security

Media & News

Brii Biosciences's Email Address Formats

Brii Biosciences uses at least 1 format(s):
Brii Biosciences Email FormatsExamplePercentage
First.Last@briibio.comJohn.Doe@briibio.com
50%
First.Last@briibio.comJohn.Doe@briibio.com
50%

Frequently Asked Questions

Where is Brii Biosciences's headquarters located?

Minus sign iconPlus sign iconBrii Biosciences's main headquarters is located at 110 North Corcoran Street Suite 05-110 Durham, North Carolina United States. The company has employees across 2 continents, including AsiaNorth America.

What is Brii Biosciences's official website and social media links?

Minus sign iconPlus sign iconBrii Biosciences's official website is briibio.com and has social profiles on LinkedInCrunchbase.

What is Brii Biosciences's SIC code NAICS code?

Minus sign iconPlus sign iconBrii Biosciences's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Brii Biosciences have currently?

Minus sign iconPlus sign iconAs of February 2026, Brii Biosciences has approximately 88 employees across 2 continents, including AsiaNorth America. Key team members include Chief Medical Officer: D. M.Chief Scientific Officer: B. J.Vice President Pharmaceutical Sciences: K. P.. Explore Brii Biosciences's employee directory with LeadIQ.

What industry does Brii Biosciences belong to?

Minus sign iconPlus sign iconBrii Biosciences operates in the Biotechnology Research industry.

What technology does Brii Biosciences use?

Minus sign iconPlus sign iconBrii Biosciences's tech stack includes NetSuiteApple iCloud MailMicrosoftMicrosoft WordMicrosoft AzurePHPGoogleX-XSS-Protection.

What is Brii Biosciences's email format?

Minus sign iconPlus sign iconBrii Biosciences's email format typically follows the pattern of First.Last@briibio.com. Find more Brii Biosciences email formats with LeadIQ.

How much funding has Brii Biosciences raised to date?

Minus sign iconPlus sign icon As of February 2026, Brii Biosciences has raised $155M in funding. The last funding round occurred on Mar 23, 2021 for $155M.

When was Brii Biosciences founded?

Minus sign iconPlus sign iconBrii Biosciences was founded in 2018.

Brii Biosciences

Biotechnology ResearchNorth Carolina, United States51-200 Employees

Brii Biosciences Limited (“Brii Bio”, stock code: 2137.HK) is a biotechnology company developing therapies to improve patients’ health by addressing high unmet medical needs with limited treatment options. The Company is advancing a broad pipeline of unique therapeutic candidates with lead programs against hepatitis B virus (HBV) infection. 

Led by a visionary and experienced leadership team, Brii Bio has deep scientific expertise and a proven ability to progress therapeutic assets from discovery to commercial approval on a consolidated timeline.

Established in 2018, Brii Bio now has operations in key biotech hubs, including Raleigh-Durham, the San Francisco Bay Area, Beijing and Shanghai. On July 13, 2021, the Company was officially listed on the Hong Kong Stock Exchange under the stock code 2137.HK.

Section iconCompany Overview

Headquarters
110 North Corcoran Street Suite 05-110 Durham, North Carolina United States
Website
briibio.com
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2018
Employees
51-200

Section iconMedia & News

Section iconFunding & Financials

  • $155M

    Brii Biosciences has raised a total of $155M of funding over 2 rounds. Their latest funding round was raised on Mar 23, 2021 in the amount of $155M.

  • $250M$500M

    Brii Biosciences's revenue is estimated to be in the range of $250M$500M

Section iconFunding & Financials

  • $155M

    Brii Biosciences has raised a total of $155M of funding over 2 rounds. Their latest funding round was raised on Mar 23, 2021 in the amount of $155M.

  • $250M$500M

    Brii Biosciences's revenue is estimated to be in the range of $250M$500M

Company Leadership

  • Stylized image of a person
    D. M.
    Chief Medical Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    B. J.
    Chief Scientific Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    K. P.
    Vice President Pharmaceutical Sciences
    Phone icon
    Mobile Phone
  • Stylized image of a person
    A. S.
    Vice President Neuroscience Ta Head Cns
    Phone icon
    Mobile Phone
  • Stylized image of a person
    E. V.
    Head Of Platform And Early Discovery Sciences
    Phone icon
    Mobile Phone

Employee Directory

  • Stylized image of a person
    A. L.
    Head，procurement，clinical Sourcing
    Phone icon
    Mobile Phone
  • Stylized image of a person
    K. P.
    Vice President Pharmaceutical Sciences
    Phone icon
    Mobile Phone
  • Stylized image of a person
    I. Y.
    Senior Director, Head Of Data Management
    Phone icon
    Mobile Phone
  • Stylized image of a person
    Q. Z.
    Head Of China R&d
    Phone icon
    Mobile Phone
  • Stylized image of a person
    R. L.
    Gm Great China, Svp
    Phone icon
    Mobile Phone

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.